FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to the field of medicine, in particular to medications, containing organic active ingredients, namely to medications, demonstrating a sedative and soporific effect, and can be used for the treatment of somatoform dysfunction of the vegetative nervous system, neuroses with an increased irritability, increased excitation, insomnia, neurocirculatory dystonia, early stage of hypertensive disease, mildly expressed spasm of the cardiac vessels, spasm of the digestive tract organs, associated with neurovegetative disorders. A solid drug form of the medication with the sedative and soporific effect in the form of tablets or hard capsules contains ethyl ether of α-bromoisovaleric acid and mint oil or its mixture with hop oil, β-cyclodextrin, doxylamine, guaifenesin and auxiliary substances, including structured water.
EFFECT: effective solid drug form of the preparation was created by increasing the sedative efficiency of Korvaltab tablets.
5 cl, 8 tbl, 8 ex
Title | Year | Author | Number |
---|---|---|---|
SOLID DOSAGE FORM OF PREPARATION OF SEDATIVE AND HYPNOTIC EFFECT | 2013 |
|
RU2589833C2 |
MEDICINE OF SEDATIVE AND ANTISPASMODIC EFFECT AND METHOD OF PREPARATION (VERSIONS) | 2005 |
|
RU2349334C2 |
SEDATIVE AND SPASMOLITHIC MEANS AND METHOD FOR ITS PRODUCTION | 2015 |
|
RU2633064C2 |
SEDATIVE AND MUSCLE RELAXANT ACTION DRUG | 2019 |
|
RU2719376C1 |
PHARMACEUTICAL COMPOSITION OF MEDICINAL AGENT OF SEDATIVE AND SPASMOLYTIC ACTION IN FORM OF SOFT GELATINE CAPSULES (VERSIONS) | 2013 |
|
RU2580290C2 |
SEDATIVE MEDICINAL PRODUCT IN THE FORM OF TABLETS | 2021 |
|
RU2770037C1 |
PHARMACEUTICAL COMPOSITION OF SEDATIVE AND ANXIOLYTIC ACTION | 2020 |
|
RU2737701C1 |
COMPOSITION AND METHOD OF PRODUCING MEDICINE | 2017 |
|
RU2675627C1 |
METHOD OF OBTAINING A SOLID FORM OF THE DRUG SEDATIVE AND ANTISPASMODIC ACTION | 2015 |
|
RU2578432C9 |
LIQUID SEDATIVE | 2021 |
|
RU2779256C1 |
Authors
Dates
2015-12-10—Published
2013-10-17—Filed